Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2025-12-26 @ 2:05 AM
Study NCT ID:
NCT01427205
Status:
WITHDRAWN
Last Update Posted:
2013-04-05
First Post:
2011-08-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-08-30
First Submit QC Date:
None
Study First Post Date:
2011-09-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-04-04
Last Update Post Date:
2013-04-05
Last Update Post Date Type:
ESTIMATED